The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hmm, down 20%. I guess the seeking additional funding in the next month was far more negative than the positive outlook.
Tracy Corrigan added to the Board's Sustainability and Nomination & Governance committees.
"From 2014 to 2020 Tracy was the Chief Strategy Officer of Dow Jones & Company, Inc where she oversaw the digital transformation of that business. She previously held a number of senior management roles within Dow Jones and the Financial Times. Tracy is a non-executive director of Direct Line Insurance Group plc (FTSE: DLG)."
Looks like a very strong addition to the board.
Looks like positive news in today's RNS. In the outlook:
"the Company is targeting a minimum of a 50% increase in average daily ore production, a 30% increase in average head grade, and a 20% reduction in monthly operating costs compared to 2021 totals."
With last month's director buys, this seem spromising.
However, this looks concerning: "The Company expects it will need to seek additional financing in the next 30 days to fund operations and to service the interest on its debt"
Surprising drop in share price this morning. The Preliminary results are about the same KPIs as last period, so not sure why the fall. Perhaps many investors were expecting a significant increase in KPIs due to increased deaths, but the deaths has remained the same as last period.
While the results look bad, they show a huge improvement over the previous year. With travel restrictions falling away, more and more people will be eager to book holiday cruises. I think this is a very good time to buy with a view to hold for at least five years.
Another solid set of annual results: revenue up 14%, profit up 30%, earnings per share up 50%, net assets up 30%.
The share price has risen about 400% over the last five years. This looks to be a good long-term hold.
Very nice news, a new contract of £1.5m, about 15% of revenue. Good to see another major telco using their products. Should see a nice steady rise.
I predicted 400p by 22nd. Don't think it's going to hit that, unfortunately.
I assume the price rise in the last few days is due to the possible Offer of 6.7p per share?
Where did you get $0.165 from? If the Offer goes ahead, the shares will be bought at 6.7p each.
The full year results look exceedings strong.
Revenue +13%, profit +60%, EPS +55%, dividend almost doubled, EPS 8.9p cf. 1.2p loss, net assets up modestly,
and a positive outlook.
The share price has recovered this month, and I expect that will continue after this news.
I'm surprised no chats posted today after these results have been announced.
- 69% increase in gold output
- Ninth consecutive year of achieving or beating annual production and AISC guidance
- Adjusted Net Earnings of $145m or $0.58/sh in Q4-2021; FY-2021 up $254m over FY-2020 to $577m (up 79% to $2.40/sh)
- Operating Cash Flow of $356m or $1.43/sh in Q4-2021; FY-2021 up $464m over FY-2020 to $1,175m (up 65% to $4.89/sh)
- Net Cash position of $76m achieved, after absorbing circa $330m of Teranga net debt
This sums it up really well
https://dilbert.com/strip/2022-03-13